Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
140.6 USD | -0.99% | +0.72% | +6.76% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.76% | 14.29B | |
+7.64% | 113B | |
+10.98% | 106B | |
+0.41% | 22.27B | |
-11.89% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-6.04% | 17.24B | |
+36.17% | 12.52B | |
+289.04% | 8.6B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Barclays Raises Neurocrine Biosciences' Price Target to $150 From $145, Maintains Overweight Rating